{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:44Z","timestamp":1789981304654,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05583-4","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:01:27Z","timestamp":1781841687000},"page":"19117-19137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular mechanism by which perfluorooctane sulfonate regulates the initiation and progression of prostate cancer via the ENTPD5\u2013adenine axis"],"prefix":"10.1007","volume":"399","author":[{"given":"Yin","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"5583_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126735","author":"S Allegrini","year":"2024","unstructured":"Allegrini S et al (2024) Interplay between mTOR and purine metabolism enzymes and its relevant role in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25126735","journal-title":"Int J Mol Sci"},{"key":"5583_CR2","doi-asserted-by":"publisher","first-page":"1519468","DOI":"10.3389\/fbinf.2025.1519468","volume":"5","author":"M Arbatsky","year":"2025","unstructured":"Arbatsky M et al (2025) Seurat function argument values in scRNA-seq data analysis: potential pitfalls and refinements for biological interpretation. Front Bioinform 5:1519468. https:\/\/doi.org\/10.3389\/fbinf.2025.1519468","journal-title":"Front Bioinform"},{"key":"5583_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70020","author":"D Chakrabarti","year":"2025","unstructured":"Chakrabarti D et al (2025) The contemporary management of prostate cancer. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.70020","journal-title":"CA Cancer J Clin"},{"key":"5583_CR4","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.7150\/ijbs.97008","volume":"21","author":"P Chan","year":"2025","unstructured":"Chan P et al (2025) Cgref1 is a CREB-H-regulated hepatokine that promotes hepatic de novo lipogenesis by mediating epididymal fat insulin resistance. Int J Biol Sci 21:2568\u20132588. https:\/\/doi.org\/10.7150\/ijbs.97008","journal-title":"Int J Biol Sci"},{"key":"5583_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-00996-0","volume":"15","author":"X Chen","year":"2022","unstructured":"Chen X et al (2022) Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78\/p-eIF-2\u03b1\/CHOP pathway in serous ovarian cancer. J Ovarian Res 15:69. https:\/\/doi.org\/10.1186\/s13048-022-00996-0","journal-title":"J Ovarian Res"},{"key":"5583_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2019.108902","volume":"181","author":"SC Chuang","year":"2020","unstructured":"Chuang SC et al (2020) Phthalate exposure and prostate cancer in a population-based nested case-control study. Environ Res 181:108902. https:\/\/doi.org\/10.1016\/j.envres.2019.108902","journal-title":"Environ Res"},{"key":"5583_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040722","author":"D Currie","year":"2024","unstructured":"Currie D et al (2024) A potential prognostic gene signature associated with p53-dependent NTRK1 activation and increased survival of neuroblastoma patients. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16040722","journal-title":"Cancers (Basel)"},{"key":"5583_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2021.116840","volume":"278","author":"X Duan","year":"2021","unstructured":"Duan X et al (2021) Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression. Environ Pollut 278:116840. https:\/\/doi.org\/10.1016\/j.envpol.2021.116840","journal-title":"Environ Pollut"},{"key":"5583_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.139914","volume":"738","author":"X Gao","year":"2020","unstructured":"Gao X et al (2020) Ecological and health risk assessment of perfluorooctane sulfonate in surface and drinking water resources in China. Sci Total Environ 738:139914. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.139914","journal-title":"Sci Total Environ"},{"key":"5583_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13808-7","volume":"25","author":"D Gao","year":"2025","unstructured":"Gao D et al (2025) CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H\/ Wnt\/\u03b2-Catenin signaling axis. BMC Cancer 25:435. https:\/\/doi.org\/10.1186\/s12885-025-13808-7","journal-title":"BMC Cancer"},{"key":"5583_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41585-024-00992-7","volume":"22","author":"S Gharbieh","year":"2025","unstructured":"Gharbieh S et al (2025) Epidemiology, diagnosis and treatment of anterior prostate cancer. Nat Rev Urol 22:439\u2013446. https:\/\/doi.org\/10.1038\/s41585-024-00992-7","journal-title":"Nat Rev Urol"},{"key":"5583_CR12","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.2147\/jir.S475645","volume":"17","author":"S Guo","year":"2024","unstructured":"Guo S et al (2024) Consensus clustering analysis identifies ferroptosis-related patient clusters and predictive signature construction based on ferroptosis-related genes in ischemic cardiomyopathy. J Inflamm Res 17:6797\u20136814. https:\/\/doi.org\/10.2147\/jir.S475645","journal-title":"J Inflamm Res"},{"key":"5583_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.eururo.2025.02.001","volume":"87","author":"C Hage Chehade","year":"2025","unstructured":"Hage Chehade C et al (2025) T-cell engagers in prostate cancer. Eur Urol 87:553\u2013558. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.001","journal-title":"Eur Urol"},{"key":"5583_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1021\/acs.chemrestox.4c00528","volume":"38","author":"A Hailemariam","year":"2025","unstructured":"Hailemariam A et al (2025) Perfluorooctane sulfonate (PFOS) and related compounds induce nuclear receptor 4A1 (NR4A1)-dependent carcinogenesis. Chem Res Toxicol 38:705\u2013716. https:\/\/doi.org\/10.1021\/acs.chemrestox.4c00528","journal-title":"Chem Res Toxicol"},{"key":"5583_CR15","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.7150\/thno.100555","volume":"14","author":"SB Hansen","year":"2024","unstructured":"Hansen SB et al (2024) Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management. Theranostics 14:6913\u20136934. https:\/\/doi.org\/10.7150\/thno.100555","journal-title":"Theranostics"},{"key":"5583_CR16","doi-asserted-by":"publisher","first-page":"179698","DOI":"10.1016\/j.scitotenv.2025.179698","volume":"994","author":"Y Hong","year":"2025","unstructured":"Hong Y (2025) Advancing network toxicology in environmental pollutants analysis: Key considerations and future perspectives from. Sci Total Environ 994:179698. https:\/\/doi.org\/10.1016\/j.scitotenv.2025.179698","journal-title":"Sci Total Environ"},{"key":"5583_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2025.126594","volume":"381","author":"W Hua","year":"2025","unstructured":"Hua W et al (2025) Perfluorooctane sulfonate exposure disrupts steroid hormone synthesis in rats via the gut-metabolism-testis axis. Environ Pollut 381:126594. https:\/\/doi.org\/10.1016\/j.envpol.2025.126594","journal-title":"Environ Pollut"},{"key":"5583_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113902","author":"OB Imir","year":"2021","unstructured":"Imir OB et al (2021) Per- and polyfluoroalkyl substance exposure combined with high-fat diet supports prostate cancer progression. Nutrients. https:\/\/doi.org\/10.3390\/nu13113902","journal-title":"Nutrients"},{"key":"5583_CR19","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1002\/cam4.4341","volume":"10","author":"Y Jin","year":"2021","unstructured":"Jin Y et al (2021) Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer Med 10:8693\u20138707. https:\/\/doi.org\/10.1002\/cam4.4341","journal-title":"Cancer Med"},{"key":"5583_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01042-6","author":"X Li","year":"2025","unstructured":"Li X et al (2025) Synergistic targeting strategies for prostate cancer. Nat Rev Urol. https:\/\/doi.org\/10.1038\/s41585-025-01042-6","journal-title":"Nat Rev Urol"},{"key":"5583_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01022-z","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Targeting purine metabolism in ovarian cancer. J Ovarian Res 15:93. https:\/\/doi.org\/10.1186\/s13048-022-01022-z","journal-title":"J Ovarian Res"},{"key":"5583_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503603","author":"R Ma","year":"2025","unstructured":"Ma R et al (2025) Hepatic ENTPD5 is critical for maintaining metabolic homeostasis and promoting brown adipose tissue thermogenesis. Adv Sci (Weinh). https:\/\/doi.org\/10.1002\/advs.202503603","journal-title":"Adv Sci (Weinh)"},{"key":"5583_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105240","volume":"106","author":"J Mietz","year":"2024","unstructured":"Mietz J et al (2024) Human effector CD8(+) T cells with an activated and exhausted-like phenotype control tumour growth in vivo in a humanized tumour model. EBioMedicine 106:105240. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105240","journal-title":"EBioMedicine"},{"key":"5583_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.eururo.2024.12.007","volume":"87","author":"SAA Naqvi","year":"2025","unstructured":"Naqvi SAA et al (2025) Heterogeneity of the treatment effect with PARP inhibitors in metastatic castration-resistant prostate cancer: a living interactive systematic review and meta-analysis. Eur Urol 87:626\u2013640. https:\/\/doi.org\/10.1016\/j.eururo.2024.12.007","journal-title":"Eur Urol"},{"key":"5583_CR25","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1007\/s00204-020-02848-6","volume":"94","author":"P Pierozan","year":"2020","unstructured":"Pierozan P et al (2020) Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) induce epigenetic alterations and promote human breast cell carcinogenesis in vitro. Arch Toxicol 94:3893\u20133906. https:\/\/doi.org\/10.1007\/s00204-020-02848-6","journal-title":"Arch Toxicol"},{"key":"5583_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152871","volume":"460","author":"J Qu","year":"2021","unstructured":"Qu J et al (2021) Perfluorooctane sulfonate interferes with non-genomic estrogen receptor signaling pathway, inhibits ERK1\/2 activation and induces apoptosis in mouse spermatocyte-derived cells. Toxicology 460:152871. https:\/\/doi.org\/10.1016\/j.tox.2021.152871","journal-title":"Toxicology"},{"key":"5583_CR27","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R et al (2025) Prostate cancer. JAMA 333:1433\u20131446. https:\/\/doi.org\/10.1001\/jama.2025.0228","journal-title":"JAMA"},{"key":"5583_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"5583_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101359","volume":"103","author":"D Senapati","year":"2025","unstructured":"Senapati D et al (2025) Targeting and engineering biomarkers for prostate cancer therapy. Mol Aspects Med 103:101359. https:\/\/doi.org\/10.1016\/j.mam.2025.101359","journal-title":"Mol Aspects Med"},{"key":"5583_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01156-w","volume":"28","author":"X Shi","year":"2023","unstructured":"Shi X et al (2023) A pan-cancer analysis of the oncogenic and immunological roles of apolipoprotein F (APOF) in human cancer. Eur J Med Res 28:190. https:\/\/doi.org\/10.1186\/s40001-023-01156-w","journal-title":"Eur J Med Res"},{"key":"5583_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2025.123324","volume":"278","author":"F Simonetti","year":"2025","unstructured":"Simonetti F et al (2025) Unveiling the adsorption mechanism of perfluorooctane sulfonate onto polypropylene nanoplastics: a combined theoretical and experimental investigation. Water Res 278:123324. https:\/\/doi.org\/10.1016\/j.watres.2025.123324","journal-title":"Water Res"},{"key":"5583_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.137249","volume":"487","author":"TY Suman","year":"2025","unstructured":"Suman TY et al (2025) Current understanding of human bioaccumulation patterns and health effects of exposure to perfluorooctane sulfonate (PFOS). J Hazard Mater 487:137249. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.137249","journal-title":"J Hazard Mater"},{"key":"5583_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.143544","volume":"759","author":"G Sunantha","year":"2021","unstructured":"Sunantha G et al (2021) A method for detecting perfluorooctanoic acid and perfluorooctane sulfonate in water samples using genetically engineered bacterial biosensor. Sci Total Environ 759:143544. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.143544","journal-title":"Sci Total Environ"},{"key":"5583_CR34","doi-asserted-by":"publisher","first-page":"E953","DOI":"10.36076\/ppj.2024.7.E953","volume":"27","author":"H Tao","year":"2024","unstructured":"Tao H et al (2024) Comparison of robot-assisted and fluoroscopy-assisted percutaneous kyphoplasty for bone cement distribution and clinical efficacy. Pain Physician 27:E953-e963","journal-title":"Pain Physician"},{"key":"5583_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/gastro\/goz011","volume":"7","author":"YB Wang","year":"2019","unstructured":"Wang YB et al (2019) Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma. Gastroenterol Rep (Oxf) 7:354\u2013360. https:\/\/doi.org\/10.1093\/gastro\/goz011","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"5583_CR36","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537","journal-title":"Nucleic Acids Res"},{"key":"5583_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01697","volume":"9","author":"J Yin","year":"2018","unstructured":"Yin J et al (2018) Potential mechanisms connecting purine metabolism and cancer therapy. Front Immunol 9:1697. https:\/\/doi.org\/10.3389\/fimmu.2018.01697","journal-title":"Front Immunol"},{"key":"5583_CR38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.envint.2019.03.002","volume":"126","author":"Z Zeng","year":"2019","unstructured":"Zeng Z et al (2019) Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies. Environ Int 126:598\u2013610. https:\/\/doi.org\/10.1016\/j.envint.2019.03.002","journal-title":"Environ Int"},{"key":"5583_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.03.008","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) Identifying patients at risk of early lethal prostate cancer by integrating family history, polygenic risk score, rare variants in DNA repair genes, and lifestyle factors. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2025.03.008","journal-title":"Eur Urol Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05583-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05583-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05583-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:14:20Z","timestamp":1789978460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05583-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5583"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05583-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors hereby confirm that all necessary consents have been obtained for the publication of this work.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}